🇺🇸 MK0826; ertapenem sodium in United States

MK0826; ertapenem sodium (MK0826; ertapenem sodium) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

MK0826; ertapenem sodium in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is MK0826; ertapenem sodium approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for MK0826; ertapenem sodium in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.